GlassScriptPhysician profile
Robert Francis Dallapiazza
NPI 1508180175
$32,719.10
in general payments reported to CMS, 2019-2025
21 companies · $15K in 2025
The $15K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,015 · 2020: $255 · 2021: $2,396 · 2022: $2,989 · 2023: $6,224 · 2024: $3,941 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,400 · Travel and Lodging: $5,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,493.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,400.00 |
| Travel and Lodging | $5,170.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,994.70 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Globus Medical, INC. | $7,234.35 | 2019-2025 | Excelsius Gps, Senza, Sable |
| Alphatec Spine, INC | $3,331.38 | 2023 | Other - Miscellaneous, Identiti |
| Medtronic, INC. | $1,793.15 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $1,153.20 | 2023-2025 | Proclaim, Eterna, Infinity |
| Biotronik Nro, INC. | $721.31 | 2024-2025 | Prospera |
| Medtronic USA, INC. | $561.52 | 2019-2020 | |
| Livanova USA, INC. | $380.06 | 2025 | Vns Therapy |
| Nevro Corp. | $348.61 | 2024 | Senza |
| Providence Medical Technology, INC. | $346.32 | 2024-2025 | |
| Microtransponder, INC. | $186.06 | 2023 | |
| Penumbra, INC. | $183.98 | 2023-2025 | Penumbra System |
| Saluda Medical Americas, INC. | $131.67 | 2025 | Evoke |
| Intrinsic Therapeutics | $108.63 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Depuy Synthes Sales INC. | $63.47 | 2023 | Symphony |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $46.74 | 2019-2021 | |
| Tricoast Surgical Solutions LLC | $42.74 | 2024 | |
| Sonex Health, INC. | $32.52 | 2023 | Sx-One Microknife |
| Collegium Pharmaceutical, INC. | $24.34 | 2023 | Xtampza |
| Neuropace, INC. | $21.26 | 2024 | |
| Brainlab, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dallapiazza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.